Competitive Positioning Strategies for Japanese Biotech Companies
Competitive Positioning Strategies for Japanese Biotech Companies
RELEASE DATE
07-Nov-2003
07-Nov-2003
REGION
Asia Pacific
Asia Pacific
Research Code: 4086-01-00-00-00
SKU: HC00081-AP-MR_02809
$1,500.00
In stock
SKU
HC00081-AP-MR_02809
Description
Japan is emerging as a force to reckon with in the global biotechnology landscape. Lately, committed support from the government and resulting administrative changes have brought the Japanese biotech industry to an inflection point. There are plenty of opportunities for Japanese biotech companies to explore and fewer hurdles on their path compared to earlier times. Japan is currently, the world's second largest pharmaceutical market and also ranks second in biotech market size when conventional biotech also is taken into consideration. This makes it a lucrative market for companies planning to enter the Japanese market too.
Table of Contents
Introduction
- Introduction
Market Overview and Opportunity Analysis
- Market Overview
- Opportunity Analysis
Introduction
Drivers
- Introduction
Biotech Market in Asia Pacific
- Market Drivers
- Protection of Intellectual Property Rights
- Low Cost R&D Base
- Availability of Public Domain Knowledge Base
Market Overview
Sectors of Activity
Key Success Factors
SWOT Analysis of Japan as a Biotech Hub
Attractiveness of Japan as a Biotech Destination for International Players
Current Competitive Position of Japan
Strategies for Achieving Competitive Success
Japan's Future Position as Biotechnology Hub
Related Research
Popular Topics
Japan is emerging as a force to reckon with in the global biotechnology landscape. Lately, committed support from the government and resulting administrative changes have brought the Japanese biotech industry to an inflection point. There are plenty of opportunities for Japanese biotech companies to explore and fewer hurdles on their path compared to earlier times. Japan is currently, the world's second largest pharmaceutical market and also ranks second in biotech market size when conventional biotech also is taken into consideration. This makes it a lucrative market for companies planning to enter the Japanese market too.
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 4086-01-00-00-00 |
Is Prebook | No |